Imodium Comp (Dimeticone, Loperamide Hydrochloride)

Loperamide acts as a peripheral μ‑opioid receptor agonist, slowing intestinal motility and reducing fluid secretion. Dimeticone lowers the surface tension of gas bubbles, allowing them to merge and be expelled more easily, which alleviates bloating and flatulence.

The appropriate dose of Imodium Comp is determined by a healthcare professional based on the individual’s age, weight, and severity of symptoms. Patients should follow the prescriber’s instructions or the product label without exceeding the recommended amount.

Safety in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Imodium Comp to weigh potential benefits against any risks.

To order Imodium Comp, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imodium Comp combines loperamide, a well‑established opioid‑based antidiarrheal, with dimeticone, an antiflatulent. This dual action can address both loose stools and gas, whereas single‑ingredient products may only target one symptom. The combination may offer broader symptomatic relief for patients experiencing both diarrhea and flatulence.

Imodium Comp should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Imodium Comp is taken orally, usually with a glass of water. The tablet or capsule should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe constipation leading to intestinal obstruction, toxic megacolon, allergic reactions such as rash or anaphylaxis, and rare cardiac arrhythmias, especially when combined with CYP3A4 inhibitors or taken in excess.

Individuals with known hypersensitivity to dimeticone or loperamide, patients with bacterial enterocolitis, acute dysentery, or unexplained high‑fever diarrhea should avoid Imodium Comp. It is also contraindicated in those with severe hepatic impairment unless specifically advised by a physician.